Avalyn Pharma Reports Update in Ongoing Idiopathic Pulmonary Fibrosis Trial

News published by Avalyn Pharma concerning AP01 (a formulation of pirfenidone optimized for delivery via inhalation), administered via an optimized eFlow^® Technology nebulizer.